References
- ECAT assay procedures: a manual of laboratory techniques. 3, J Jespersen, R. M Bertina, F Haverkate, 1992
- Brummel K. E., Paradis S. G., Butenas S., Mann K. G. Thrombin functions during tissue factor‐induced blood coagulation. Blood 2002; 100: 148–52
- Sørensen B., Johansen P., Christiansen K., Wöelke M., Ingerslev J. Whole blood coagulation thrombelastographic profiles employing minimal tissue factor activation. J Thromb Haemost 2003; 1: 551–8
- Ingerslev J., Poulsen L. H., Sørensen B. Potential role of the dynamic properties of whole blood coagulation in assessment of dosage requirements in haemophilia. Haemophilia 2003; 9: 348–52
- Fenger‐Eriksen C., Anker‐Moller E., Heslop J., Ingerslev J., Sørensen B. Thrombelastographic whole blood clot formation after ex vivo addition of plasma substitutes: improvements of the induced coagulopathy with fibrinogen concentrate. Br J Anaesth 2005; 94: 324–9
- Sørensen B., Ingerslev J. Whole blood clot formation phenotypes in hemophilia A and rare coagulation disorders. Patterns of response to recombinant factor VIIa. J Thromb Haemost 2004; 2: 102–10
- Sørensen B., Ingerslev J. Thromboelastography and recombinant factor VIIa‐hemophilia and beyond. Semin Hematol 2004; 41(Suppl 1)140–4
- Sørensen B., Johansen P., Nielsen G. L., Sorensen J. C., Ingerslev J. Reversal of the International Normalized Ratio with recombinant activated factor VII in central nervous system bleeding during warfarin thromboprophylaxis: clinical and biochemical aspects. Blood Coagul Fibrinolysis 2003; 14: 469–77
- Dahlback B., Carlsson M., Svensson P. J. Familial thrombophilia due to a previously unrecognized mechanism characterized by poor anticoagulant response to activated protein C: prediction of a cofactor to activated protein C. Proc Natl Acad Sci USA 1993; 90: 1004–8
- Gaustadnes M., Rudiger N., Ingerslev J. The 20210 A allele of the prothrombin gene is not a risk factor for juvenile stroke in the Danish population. Blood Coagul Fibrinolysis 1998; 9: 663–4
- Rasmussen K., Moller J., Lyngbak M., Pedersen A. M., Dybkjaer L. Age‐ and gender‐specific reference intervals for total homocysteine and methylmalonic acid in plasma before and after vitamin supplementation. Clin Chem 1996; 42: 630–6
- Ingerslev J., Christiansen K., Calatzis A., Holm M., Sabroe E. L. Management and monitoring of recombinant activated factor VII. Blood Coagul Fibrinolysis 2000; 11(Suppl 1)S25–30
- Oshita K., Az‐ma T., Osawa Y., Yuge O. Quantitative measurement of thromboelastography as a function of platelet count. Anesth Analg 1999; 89: 296–9
- Tripodi A., Chantarangkul V., Martinelli I., Bucciarelli P., Mannucci P. M. A shortened activated partial thromboplastin time is associated with the risk of venous thromboembolism. Blood 2004; 104: 3631–4
- Rivard G. E., Brummel‐Ziedins K. E., Mann K. G., Fan L., Hofer A., Cohen E. Evaluation of the profile of thrombin generation during the process of whole blood clotting as assessed by thrombelastography. J Thromb Haemost 2005; 3: 2039–43
- Brummel‐Ziedins K. E., Vossen C. Y., Butenas S., Mann K. G., Rosendaal F. R. Thrombin generation profiles in deep venous thrombosis. J Thromb Haemostasis 2005; 3: 2497–505